Novo Nordisk A/S (NYSE:NVO)

56.65
Delayed Data
As of Apr 24
 +0.44 / +0.78%
Today’s Change
41.72
Today|||52-Week Range
56.92
+33.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
AssetsCash487.3M918.4M2.1B2.3B
 
 
 
 
 
Short Term Investment Cash-1.6B504.4M1.3B324.1M
 
 
 
 
 
Cash & Short Term Investments1.1B1.2B2.3B2.6B
 
 
 
 
 
 
ReceivablesReceivables3.3B2.6B2.3B2.9B
 
 
 
 
 
 
InventoriesInventories1.9B2.0B1.9B1.8B
 
 
 
 
 
 
Current AssetsPrepaid Expenses------198.6M
 
 
Other Current Assets0.00522.7M508.4M0.00
 
 
 
Current Assets6.4B6.3B7.0B7.5B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------7.7B
 
 
Depreciation-------4.0B
 
 
Intangible Assets310.9M313.9M237.2M223.9M
 
 
 
 
 
Other Assets310.9M313.9M237.2M223.9M
 
 
 
 
 
Total Assets11.7B11.7B12.1B12.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable644.3M548.7M507.1M804.4M
 
 
 
 
 
Short Term Debt148.4M74.6M48.2M117.0M
 
 
 
 
 
Accrued Expenses------746.9M
 
 
Other Current Liabilities3.6B3.5B4.0B3.3B
 
 
 
 
 
Other Liabilities4.9B4.4B5.1B5.5B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-716.2M-803.7M-894.0M-876.2M
 
 
 
 
 
Other Liabilities0.00-0.000.000.00
 
 
 
Total Liabilities5.5B5.0B5.7B6.0B
 
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.000.000.000.00--
Common Equity6.2B6.7B6.4B6.5B
 
 
 
 
 
Total Shareholder Equity6.2B6.7B6.4B6.5B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.2B2.1B2.1B2.1B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account